Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation for Children With Non-Malignant Diseases Who Have Been Multiply Transfused: a Pilot Study

NCT01319851 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT01319851
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01319851 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation for Children With Non-Malignant Diseases Who Have Been Multiply Transfused: a Pilot Study
Lead sponsor
Emory University
Phase
Not applicable
Overall status
Terminated
Start date
September 30, 2010
Completion date
September 30, 2013
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chediak-higashi syndrome, chronic-granulomatous disease, diamond-blackfan anemia, dyskeratosis-congenita, fanconi anemia, glanzmann thrombasthenia, leukocyte adhesion deficiency, schwachman-diamond syndrome, severe aplastic anemia, severe congenital neutropenia, sickle cell disease, thalassemia, wiskott-aldrich syndrome